Deep Apple Therapeutics
CA - San FranciscoBiotechnology
Focus: Deep Apple Therapeutics is a public-stage biotechnology company headquartered in San Francisco focused on oral small molecule drug development. The company operates at an early stage with minimal public visibility into its pipeline or commercial products.
Profile data last refreshed 42m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Deep Apple Therapeutics?
AI assessmentEarly-stage biotech with promising oral small molecule focus, but extreme data opacity and minimal hiring activity warrant cautious evaluation.
Why Work Here
- Early-stage oral small molecule platform offers opportunity to shape drug discovery and development from foundational stages
- Public company status provides potential equity upside and greater transparency than private peers
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Deep Apple Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.